The graft-versus-leukemia effects of allogeneic cell therapy.
about
A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]Immunotherapy of childhood cancer: from biologic understanding to clinical application.Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).Gene transfer and the treatment of haematological malignancy.Chronic myelogenous leukemia: laboratory diagnosis and monitoring.Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.Gene therapy for paediatric leukaemia.Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.Immunomodulatory gene therapy for haematological malignancies.CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia.Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Options for T-cell based therapies.Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.Cellular therapies in acute lymphoblastic leukemiaImmunotherapy for pediatric leukemia.ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokinesGenetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Treatment of lymphoma with adoptively transferred T cells.Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen.Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.Cellular therapies in acute lymphoblastic leukemia.Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.Long-term proliferation and survival of in vitro-activated T cells is dependent on Interleukin-2 receptor signalling but not on the high-affinity IL-2R.
P2860
Q24801336-1DB7F289-E977-4850-95BA-3A8B786972AFQ33752982-A94D4B5D-1D66-426E-8AC8-E68761296D8DQ34135678-3A01AD26-27D0-44F7-88D4-25120BC535BBQ34216677-D31FCC92-73FB-4A65-91CA-711D5696C504Q34364223-81058125-649D-4B2D-9352-540345515131Q34407897-3772A514-AAD7-4105-A095-82374C89E9B8Q34451905-5C252492-821B-404E-AC6E-3837FABE09BEQ34561047-6A68147D-5A40-4329-B85E-86B33B1E1227Q34579664-0BA04CE7-8F56-43C6-A984-682645AD9A65Q34667972-B9FCDD73-4EE3-4717-8636-2F154E83F2E3Q35083003-D72EA717-9B30-4278-AA72-06570AC1A2A6Q35142329-21B9EC88-A1CE-4B53-8459-6C3BC363F207Q35813115-2A7BEA27-9A15-4AC5-9D6E-288309BED58BQ35847820-B190CAB5-F53E-4FE6-8836-6EBCD0D83C63Q36552098-0CCB5DBE-3A6C-4C40-9D17-C9A6F8F90451Q36968163-F6E4B04A-48C7-4CC7-B7A0-DF1F752F8EC5Q37162871-D984B7FB-14B6-45CB-812F-E4A646A6DBB1Q37416883-E6A9B38F-F3AC-437E-9FF7-C62113BD2901Q37419728-6617B441-B567-451C-8755-8F5CDF38C391Q38066860-C72E00DB-7AB4-4FE7-8938-410C3B900030Q38219579-913C8007-35E3-45AF-8946-A23077B8C7B0Q38905932-2DD07657-04CE-4904-BA2C-511A64A1CC70Q39122603-21B9D65D-F34A-412D-919C-62E9AD5415FAQ40590332-DD33D19B-D30F-46D9-B463-D002B151423DQ41560177-8AA8DB3F-22C8-47EF-9E94-7516D7899E08Q43710389-A174373D-2457-484F-8806-81BB4A3325B2Q43808469-22F333F8-C5F8-40AE-91DC-76A1E0893B85Q52004191-452C0B1E-305A-45DC-B161-74593C65699E
P2860
The graft-versus-leukemia effects of allogeneic cell therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The graft-versus-leukemia effects of allogeneic cell therapy.
@ast
The graft-versus-leukemia effects of allogeneic cell therapy.
@en
The graft-versus-leukemia effects of allogeneic cell therapy.
@nl
type
label
The graft-versus-leukemia effects of allogeneic cell therapy.
@ast
The graft-versus-leukemia effects of allogeneic cell therapy.
@en
The graft-versus-leukemia effects of allogeneic cell therapy.
@nl
prefLabel
The graft-versus-leukemia effects of allogeneic cell therapy.
@ast
The graft-versus-leukemia effects of allogeneic cell therapy.
@en
The graft-versus-leukemia effects of allogeneic cell therapy.
@nl
P1476
The graft-versus-leukemia effects of allogeneic cell therapy.
@en
P2093
P304
P356
10.1146/ANNUREV.MED.50.1.369
P577
1999-01-01T00:00:00Z